1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Seasonal variation of vasopressin and its relevance for the winter peak of cardiometabolic disease : A pooled analysis of five cohorts
(
- Contribution to journal › Article
- 2021
-
Mark
Copeptin as a marker of atherosclerosis and arteriosclerosis
(
- Contribution to journal › Article
- 2020
-
Mark
High water intake and low urine osmolality are associated with favorable metabolic profile at a population level : low vasopressin secretion as a possible explanation
(
- Contribution to journal › Article
- 2019
-
Mark
Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity
(
- Contribution to journal › Article
- 2018
-
Mark
The vasopressin system in the risk of diabetes and cardiorenal disease, and hydration as a potential lifestyle intervention
(
- Contribution to journal › Article
- 2017
-
Mark
Effect of increased water intake on plasma copeptin in healthy adults
(
- Contribution to journal › Article
- 2016
-
Mark
Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population
(
- Contribution to journal › Article
- 2012
-
Mark
THE VASOPRESSIN SYSTEM IN DIABETES MELLITUS, OBESITY AND THE METABOLIC SYNDROME
(
- Thesis › Doctoral thesis (compilation)